Genetic Technologies Ltd (ASX: GTG) under the health-care segment, deals in the non-coding regions of the genome and other genetic research and testing, and the company is into licensing of biotechnology patents. The company’s official listing year is 1987 and is based in Hanover Street, Fitzroy, Australia.
Latest Topics
Genetic Technologies (ASX:GTG) announces US$6.56M Direct Offering, shares jump ~33%
A diversified molecular diagnostics player, Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE) has entered into agreements with a number of institutional investors to purchase and sell in a registered direct offering of 1.25 million ADSs (American D...
- January 22, 2021 01:57 PM AEDT
- Kunal Sawhney
Genetic Technologies (ASX:GTG) shares rise after announcement of new CEO
Molecular diagnostics player Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE) today announced Simon Morriss’s appointment as the CEO of the Company. Mr Morriss will commence his role starting 1 February 2021. Post the announcement, GTG shar...
- January 04, 2021 04:28 PM AEDT
- Team Kalkine
Why did the Genetic Signatures’ (ASX:GSS) shares close ~19% higher?
Summary Genetic Signatures has acquired Boston Medical Center (BMC) for the supply of its SARS-CoV-2 detection kits. The new agreement will offer BMC with an increased testing capability. The Company also highlighted that the broader applicati...
- December 23, 2020 06:43 PM AEDT
- Kunal Sawhney
Genetic Technologies (ASX:GTG) obtains US, ANZ distribution rights of Taliaz’s PREDICTIX | AUS |
Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has entered into a partnership agreement with Taliaz, a mental health company. The three-year agreement is for the distribution right of PREDICTIX products in Austral...
- December 01, 2020 09:24 PM AEDT
- Team Kalkine
